PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population

• Main Authors: Lulu Rong (Author), Yong Liu (Author), Zhouguang Hui (Author), Zitong Zhao (Author), Yueming Zhang (Author), Bingzhi Wang (Author), Yanling Yuan (Author), Wenbin Li (Author), Lei Guo (Author), Jianming Ying (Author), Yongmei Song (Author), Luhua Wang (Author), Zhongren Zhou (Author), Liyan Xue (Author), Ning Lu (Author)
• Format: Book
• Published: BMC, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Programmed death ligand 1 (PD-L1) is a ligand for the inhibitory programmed cell death protein 1 (PD-1), which are targeted by several anti-PD-1 and PD-L1 drugs for a variety of human cancers. However, only a few studies have evaluated PD-L1 expression in esophageal squamous cell...